Ditchcarbon
  • Customers
  1. Organizations
  2. Ipsen Pharma SAS
Public Profile
FR
updated 5 months ago

Ipsen Pharma SAS

Company website

Ipsen Pharma SAS, a leading global biopharmaceutical group headquartered in France, is renowned for its innovative approach in the healthcare industry. Founded in 1929, Ipsen has established a strong presence in key operational regions, including Europe, North America, and Asia. The company focuses on developing and commercialising specialty medicines in areas such as oncology, neuroscience, and rare diseases. Ipsen's core products, including Somatuline® and Dysport®, are distinguished by their unique formulations and targeted therapeutic applications, addressing critical patient needs. With a commitment to research and development, Ipsen has achieved notable milestones, positioning itself as a trusted partner in the biopharmaceutical landscape. The company’s dedication to improving patient outcomes has solidified its reputation as a leader in the industry.

Parent Company Available

We don't have data for Ipsen Pharma SAS, but we can show you information about their parent organization instead.

View parent company

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers

Ditchcarbon
v250809.1
enquiries@ditchcarbon.com+44 203 475 7875Ditch Carbon Ltd167-169 Great Portland StreetLondon W1W 5PF
Verified byUL Verified
Partnered withCDP
ProductPortalDataDocumentationIntegrationsChangelogPricing
SolutionsProcurement teamsSustainability teamsPlatform ownersCarbon accountants
ResourcesMethodologyBlogFAQOrganizationsIndustriesSBTI APITrust Centre
AboutTeamCareersLicense AgreementPrivacy